Evidence map›Paper›PMID 15821871›Full record

ArticlePlant molecular biology2005

Recombinant human acid beta-glucosidase stored in tobacco seed is stable, active and taken up by human fibroblasts.

Serena Reggi, Stefano Marchetti, Tamara Patti, Francesca De Amicis, Roberta Cariati, Bruno Bembi, Corrado Fogher

Abstract read
PubMed Publisher
In one paragraph

Article in Plant molecular biology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.5field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 52 citations in OpenAlex.

  1. Glyco-Engineering of Plant-Based Expression Systems.Advances in biochemical engineering/biotechnology · 2021
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Serena ReggiPlantechno srl, Via Staffolo 60, Vicomoscano, 26040 Cremona, Italy.
Stefano Marchetti
Tamara Patti
Francesca De Amicis
Roberta Cariati
Bruno Bembi
Corrado Fogher
University of Udine · ITAREA Science Park · ITIRCCS Materno Infantile Burlo Garofolo · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITPlantechno (Italy) · ITUniversità Cattolica del Sacro Cuore · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gaucher disease, the most common genetic lysosomal disorder, is caused by the lack of functional acid beta-glucosidase (GCase) and is currently treated at a very high cost by enzyme replacement therapy. In an attempt to provide a safe and cost-effective production system, human placental GCase was produced and purified from transgenic tobacco seeds. Plant-derived recombinant GCase was found to be enzymatically active, uptaken by human fibroblasts and free of immunogenic xylose and fucose residues. This report demonstrates the potential of plant bioreactors in the large-scale production of injectable proteins required for lifelong therapy.

Indexed as

Blotting, WesternFemaleFibroblastsGaucher DiseaseGlucosylceramidaseHumansMicroscopy, ImmunoelectronMutation, MissenseNicotianaPlacentaPlant ProteinsPlants, Genetically ModifiedPlasmidsPolysaccharidesRecombinant Fusion ProteinsSeedsGlucosylceramidasePlant ProteinsPolysaccharidesRecombinant Fusion Proteins

Identifiers

PMID15821871
OpenAlexW2021738085

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.